GlassScriptPhysician profile
Kate Bridges
NPI 1134667033
$4,191.55
in general payments reported to CMS, 2019-2025
12 companies · $666 in 2025
The $666 reported for 2025 was more than what 78% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $771 · 2022: $1,980 · 2023: $107 · 2024: $667 · 2025: $666.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,414 · Education: $27.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,413.56 |
| Education | $27.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,011.37 | 2021-2025 | Proclaim, Eterna, Ionicrf |
| Medtronic, INC. | $1,634.09 | 2021-2024 | Synchromedii, Accurian |
| Biodelivery Sciences International, INC. | $151.70 | 2021 | |
| Abbvie INC. | $90.93 | 2021-2023 | |
| Collegium Pharmaceutical, INC. | $69.23 | 2021-2024 | Xtampza |
| Biohaven Pharmaceuticals, INC. | $67.74 | 2021 | |
| Arbor Pharmaceuticals, INC. | $61.01 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $31.59 | 2024 | Acthar |
| Novartis Pharmaceuticals Corporation | $22.63 | 2021 | |
| Scilex Pharmaceuticals INC. | $19.63 | 2021 | |
| Baudax Bio INC. | $16.23 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $15.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kate Bridges listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.